Corticosteroids for bacterial meningitis [3]

New England Journal of Medicine

Volumn 358, Issue 13, 2008, Pages 1400-

  Taha, Muhamed Kheir ^a   Alonso, Jean Michel ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID DERIVATIVE; DEXAMETHASONE; GLUCOCORTICOID;

BACTERIAL MENINGITIS; CLINICAL PRACTICE; HAEMOPHILUS INFLUENZAE; HEALTH CARE ORGANIZATION; HUMAN; LETTER; MEDICAL SOCIETY; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; GENETICS; GENOTYPE; MICROBIOLOGY; NEISSERIA MENINGITIDIS; NOTE; STREPTOCOCCUS PNEUMONIAE;

GENOTYPE; GLUCOCORTICOIDS; HUMANS; MENINGITIS, BACTERIAL; NEISSERIA MENINGITIDIS; STREPTOCOCCUS PNEUMONIAE;

EID: 41449104499     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Scarborough M, Gordon SB, Whitty CJM, et al. Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa. N Engl J Med 2007;357:2441-50.
2. Mai NTH, Chau TTH, Thwaites G, et al. Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis. N Engl J Med 2007;357:2431-40.
3. Sjostrom K, Spindler C, Ortqvist A, et al. Clonal and capsular types decide whether pneumococci will act as a primary or opportunistic pathogen. Clin Infect Dis 2006;42:451-9.
4. Trotter CL, Fox AJ, Ramsay ME, et al. Fatal outcome from meningococcal disease - an association with meningococcal phenotype but not with reduced susceptibility to benzylpenicillin. J Med Microbiol 2002;51:855-60.
5. Zarantonelli ML, Lancellotti M, Deghmane AE, et al. Hyperinvasive genotypes of Neisseria meningitidis in France. Clin Microbiol Infect (in press).